AI assistant
Sending…
AGRONOMICS LIMITED — Major Shareholding Notification 2013
Apr 12, 2013
7474_rns_2013-04-12_ead04ba0-c7c4-4c21-8bbe-b4960f756351.html
Major Shareholding Notification
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 2703C
Port Erin Biopharma Investments Ltd
12 April 2013
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii |
Port Erin Biopharma Investments Limited | ||||
| 2 Reason for the notification (please tick the appropriate box or boxes): | |||||
| An acquisition or disposal of voting rights | X | ||||
| An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |||||
| An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | |||||
| An event changing the breakdown of voting rights | |||||
| Other (please specify): | |||||
| 3. Full name of person(s) subject to the notification obligation: iii |
Webb Capital Asset Management Limited | ||||
| 4. Full name of shareholder(s) (if different from 3.):iv | BNP Paribas (Nominees) Limited a/c SF Webb Capital Smaller Companies Growth Fund State Street Nominees Limited a/c Elite Webb Capital Smaller Companies Income & Growth Fund |
||||
| 5. Date of the transaction and date on which the threshold is crossed or reached: v |
09/04/2013 | ||||
| 6. Date on which issuer notified: | 10/04/2013 | ||||
| 7. Threshold(s) that is/are crossed or reached: vi, vii |
18%, 17%,16%15%, 14%, 13% | ||||
| 8. Notified details: | ||||||||||||||||
| A: Voting rights attached to shares viii, ix | ||||||||||||||||
| Class/type of shares if possible using the ISIN CODE |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction | ||||||||||||||
| Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights x | ||||||||||||
| Direct | Direct xi | Indirect xii | Direct | Indirect | ||||||||||||
| Ordinary 0.0001p | 6,260,000 | 6,260,000 | 4,260,000 | 4,260,000 | 12.91% | 12.91% | ||||||||||
| IM00B6QH1J21 | ||||||||||||||||
| B: Qualifying Financial Instruments | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument |
Expiration date xiii |
Exercise/ Conversion Period xiv |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
% of voting rights |
||||||||||||
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument |
Exercise price | Expiration date xvii | Exercise/ Conversion period xviii |
Number of voting rights instrument refers to | % of voting rights xix, xx | |||||||||||
| Nominal | Delta | |||||||||||||||
| Total (A+B+C) | ||||||||||||||||
| Number of voting rights | Percentage of voting rights | |||||||||||||||
| 4,260,000 | 12.91% | |||||||||||||||
| 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi |
||
| SF Webb Capital Smaller Companies Growth Fund (11.02%) Elite Webb Capital Smaller Companies Income and Growth Fund (1.89%) |
||
| Proxy Voting: | ||
| 10. Name of the proxy holder: | ||
| 11. Number of voting rights proxy holder will cease to hold: |
||
| 12. Date on which proxy holder will cease to hold voting rights: |
||
| 13. Additional information: | ||
| 14. Contact name: | Peter Webb | |
| 15. Contact telephone number: | 020 7634 9510 | |
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLITMJTMBBBBAJ
More from AGRONOMICS LIMITED
Regulatory Filings
2026
Jun 4
Regulatory Filings
2026
Jun 4
Net Asset Value
2026
May 18
Capital/Financing Update
2026
May 12
Capital/Financing Update
2026
May 7
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 25
Regulatory Filings
2026
Mar 19
Director's Dealing
2026
Mar 12